A prospective study of dietary selenium intake and risk of type 2 diabetes

BMC Public Health, Sep 2010

Background Growing evidence raises concern about possible associations of high selenium exposure with diabetes in selenium-replete populations such as the US. In countries with lower selenium status, such as Italy, there is little epidemiological evidence on the association between selenium and diabetes. This study examined the prospective association between dietary selenium intake and risk of type 2 diabetes. Methods The ORDET cohort study comprised a large sample of women from Northern Italy (n = 7,182). Incident type 2 diabetes was defined as a self-report of a physician diagnosis, use of antidiabetic medication, or a hospitalization discharge. Dietary selenium intake was measured by a semi-quantitative food-frequency questionnaire at the baseline examination (1987-1992). Participants were divided in quintiles based on their baseline dietary selenium intake. Results Average selenium intake at baseline was 55.7 μg/day. After a median follow-up of 16 years, 253 women developed diabetes. In multivariate logistic regression analyses, the odds ratio for diabetes comparing the highest to the lowest quintile of selenium intake was 2.39, (95% CI: 1.32, 4.32; P for linear trend = 0.005). The odds ratio for diabetes associated with a 10 μg/d increase in selenium intake was 1.29 (95% CI: 1.10, 1.52). Conclusions In this population, increased dietary selenium intake was associated with an increased risk of type 2 diabetes. These findings raise additional concerns about the association of selenium intake above the Recommended Dietary Allowance (55 μg/day) with diabetes risk.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

http://www.biomedcentral.com/content/pdf/1471-2458-10-564.pdf

A prospective study of dietary selenium intake and risk of type 2 diabetes

Saverio Stranges 0 Sabina Sieri 2 Marco Vinceti 1 Sara Grioni 2 Eliseo Guallar 5 6 Martin Laclaustra 5 6 Paola Muti 4 Franco Berrino 3 Vittorio Krogh 2 0 Health Sciences Research Institute, University of Warwick Medical School , Coventry , UK 1 Department of Public Health Sciences, University of Modena and Reggio Emilia , Modena , Italy 2 Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan , Italy 3 Etiological and Preventive Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan , Italy 4 Epidemiology and Prevention Unit, Regina Elena Italian National Cancer Institute , Rome , Italy 5 Department of Cardiovascular Epidemiology and Population Genetics, National Center for Cardiovascular Research (CNIC) , Madrid , Spain 6 Departments of Epidemiology and Medicine, and Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD , USA Background: Growing evidence raises concern about possible associations of high selenium exposure with diabetes in selenium-replete populations such as the US. In countries with lower selenium status, such as Italy, there is little epidemiological evidence on the association between selenium and diabetes. This study examined the prospective association between dietary selenium intake and risk of type 2 diabetes. Methods: The ORDET cohort study comprised a large sample of women from Northern Italy (n = 7,182). Incident type 2 diabetes was defined as a self-report of a physician diagnosis, use of antidiabetic medication, or a hospitalization discharge. Dietary selenium intake was measured by a semi-quantitative food-frequency questionnaire at the baseline examination (1987-1992). Participants were divided in quintiles based on their baseline dietary selenium intake. Results: Average selenium intake at baseline was 55.7 g/day. After a median follow-up of 16 years, 253 women developed diabetes. In multivariate logistic regression analyses, the odds ratio for diabetes comparing the highest to the lowest quintile of selenium intake was 2.39, (95% CI: 1.32, 4.32; P for linear trend = 0.005). The odds ratio for diabetes associated with a 10 g/d increase in selenium intake was 1.29 (95% CI: 1.10, 1.52). Conclusions: In this population, increased dietary selenium intake was associated with an increased risk of type 2 diabetes. These findings raise additional concerns about the association of selenium intake above the Recommended Dietary Allowance (55 g/day) with diabetes risk. - Background Selenium is a key component of a number of selenoproteins involved in essential enzymatic functions, such as redox homeostasis, thyroid hormone metabolism, immunity and reproduction [1]. Because of antioxidant properties of selenoproteins, and because selenate mimics insulin activity in experimental models [2,3], selenium was expected to prevent type 2 diabetes and cardiovascular disease (CVD) [4]. However, recent findings from observational studies and randomised clinical trials have raised concerns with respect to possible adverse cardiometabolic effects of high selenium exposure, at least in well-nourished populations. Specifically, several unrelated studies from the US indicate that high selenium status or selenium supplementation is associated with an increased diabetes risk [5-8]. Furthermore, recent evidence from several populations indicates that high selenium exposure may also be associated with an adverse lipid profile [9-12] and hypertension [13], raising additional concerns about metabolic toxicity of high selenium exposure and prolonged use of selenium supplements [14]. Dietary intake of selenium varies considerably between countries and regions largely due to the variability of the selenium content of soil and hence of plant foods and animal forage [15]. Current recommendations on selenium intake are based on optimizing the activity of plasma glutathione peroxidases, which are maximized at intakes as high as 55 g/day [16]. In the US, selenium intake ranges from 60-220 g/day [8,12,13,15] and it is unclear if there are health benefits of increased selenium intake above the Recommended Dietary Allowance (RDA), or if metabolic toxicity might occur at these levels. Selenium intakes in Europe are lower than in the US, but with large between-country variability ranging from adequate or marginally adequate (Western and Central Europe: 30-90 g/day) to low or deficient intake (Eastern European countries: 7-30 g/day) [15]. There is little epidemiological evidence on the association of selenium with diabetes among European populations [17,18]. The objective of the present study was thus to examine the association of dietary selenium intake with risk of incident type 2 diabetes in the ORDET cohort study, a large sample of women from Northern Italy [19]. Methods Study population The ORDET study (HORmones and Diet in the ETiology of Breast Cancer) is an ongoing prospective follow (...truncated)


This is a preview of a remote PDF: http://www.biomedcentral.com/content/pdf/1471-2458-10-564.pdf

Saverio Stranges, Sabina Sieri, Marco Vinceti, Sara Grioni, Eliseo Guallar, Martin Laclaustra, Paola Muti, Franco Berrino, Vittorio Krogh. A prospective study of dietary selenium intake and risk of type 2 diabetes, BMC Public Health, 2010, pp. 564, 10, DOI: 10.1186/1471-2458-10-564